Tobias Herold Selected Research

Protein Isoforms (Isoforms)

1/2020

Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Herold Research Topics

Disease

28	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 12/2012
20	Neoplasms (Cancer) 11/2023 - 11/2005
10	Leukemia 01/2023 - 09/2013
5	COVID-19 01/2022 - 01/2020
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2020
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2022 - 12/2021
2	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 07/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 12/2014
2	Disease Progression 01/2020 - 01/2018
2	Hypoxia (Hypoxemia) 12/2015 - 07/2015
1	Hemorrhage 01/2022
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Inflammation (Inflammations) 07/2020
1	Residual Neoplasm 01/2020
1	Migraine Disorders (Migraine) 12/2019
1	Pathologic Complete Response 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Carcinogenesis 01/2016
1	Aneuploidy (Aneuploid) 01/2016

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2019
4	Oxygen (Dioxygen)IBA 01/2022 - 07/2015
2	ProteomeIBA 01/2023 - 12/2022
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 01/2014
2	venetoclaxIBA 12/2022 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2022 - 12/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2012
2	Long Noncoding RNAIBA 01/2022 - 09/2020
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2013
2	RNA Splicing FactorsIBA 10/2020 - 01/2020
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2012
1	Chimeric Antigen ReceptorsIBA 11/2023
1	ADAM10 ProteinIBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2022
1	AntibodiesIBA 01/2022
1	magrolimabIBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2022
1	AlbuminsIBA 01/2022
1	EpitopesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	EnzymesIBA 01/2021
1	olaparibIBA 01/2021
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	5-hydroxymethylcytosineIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	CreatinineIBA 07/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020
1	NucleosidesIBA 01/2020
1	ProdrugsIBA 01/2020
1	nelarabine (506U78)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	ibrutinibIBA 01/2020
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	Calcitonin Receptors (Calcitonin Receptor)IBA 12/2019
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 12/2019
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	CCAAT-Enhancer-Binding ProteinsIBA 10/2018
1	InflammasomesIBA 11/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2016
1	Complement System Proteins (Complement)IBA 11/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2016
1	NucleotidesIBA 01/2016
1	Poly(amidoamine)IBA 01/2016
1	flt3 ligand protein (flt3 ligand)IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 12/2015
1	CytokinesIBA 12/2015
1	OTS167IBA 12/2014

Therapy/Procedure

10	Therapeutics 01/2023 - 12/2014
5	Drug Therapy (Chemotherapy) 01/2023 - 07/2015
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 07/2020
1	Investigational Therapies (Experimental Therapy) 05/2023
1	Combination Drug Therapy (Combination Chemotherapy) 12/2022
1	Immunotherapy 01/2022
1	Cell Transplantation 01/2022
1	Critical Care (Surgical Intensive Care) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2018
1	Induction Chemotherapy 01/2018